Long-term disability and progression in spinal onset multiple sclerosis

被引:0
|
作者
Bedile Irem Tiftikcioglu
Irem Ilgezdi
Yasar Zorlu
Ufuk Sener
Figen Tokucoglu
机构
[1] TCSB Izmir Tepecik Education and Research Hospital,Department of Neurology
来源
Acta Neurologica Belgica | 2018年 / 118卷
关键词
Multiple sclerosis; Initial relapse; Spinal cord; Progression; Recovery; Outcome;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study is to investigate the long-term effects of the initial spinal cord (SC) involvement in MS patients. In this retrospective, single-center study, 824 patients with definite MS were screened. A total of 348 patients were excluded for ambiguous documentation of the initial relapse, pediatric onset, diagnosis of primary progressive disease, irregular assessments or visits causing doubt on the onset of progression time, and clinical follow-up duration less than 12 months. Eventually, 476 MS patients were included. Data regarding the demographics, initial symptoms, the degree of recovery from the initial relapse, neuroimaging, cerebrospinal fluid analysis, long-term disability, and progression were collected from the medical registry. The mean duration of follow-up was 7.49 ± 5.30 years. The percentage of patients entering the progressive disease course was 23.3 in the whole group. A total of 157 patients (33.0%) had SC involvement during the first clinical relapse. These patients were significantly older at disease onset (31.69 ± 10.18 vs. 29.55 ± 9.49; p = 0.028), had higher rates of progression (32.5 vs. 18.8%; p = 0.001), and had higher disability scores in long-term follow-up (3.41 ± 2.19 vs. 2.62 ± 1.81; p < 0.001). Mean age at the transition of progressive phase was 41.4 ± 11.2 years. The degree of recovery from the initial relapse significantly affected the long-term disability. The poor recovery from the initial relapse was associated with older onset age and higher EDSS scores. Being older than 40 years during MS onset and poor recovery from the initial relapse exerted an increased risk for progression. The initial SC involvement was related to a more severe relapse with less chance of complete recovery and higher risk for progression. Confirmation of risk factors in different MS cohorts would increase our understanding of the complex disease mechanisms.
引用
收藏
页码:217 / 225
页数:8
相关论文
共 50 条
  • [1] Long-term disability and progression in spinal onset multiple sclerosis
    Tiftikcioglu, Bedile Irem
    Ilgezdi, Irem
    Zorlu, Yasar
    Sener, Ufuk
    Tokucoglu, Figen
    ACTA NEUROLOGICA BELGICA, 2018, 118 (02) : 217 - 225
  • [2] Long-term disability progression of pediatric-onset multiple sclerosis
    Mckay, Kyla A.
    Hillert, Jan
    Manouchehrinia, Ali
    NEUROLOGY, 2019, 92 (24) : E2764 - E2773
  • [3] Long-term disability progression of paediatric-onset multiple sclerosis
    McKay, K. A.
    Hillert, J.
    Manouchehrinia, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 544 - 544
  • [4] Long-term disability progression in childhood and adolescent onset multiple sclerosis patients
    De Meo, Ermelinda
    Bonacchi, Raffaello
    Fonderico, Mattia
    Filippi, Massimo
    Patti, Francesco
    Morra, Vincenzo Brescia
    Salemi, Giuseppe
    Lus, Giacomo
    Onofrj, Marco
    Cocco, Eleonora
    Maniscalco, Giorgia
    Bertolotto, Antonio
    Confalonieri, Paolo
    Bergamaschi, Roberto
    Lugaresi, Alessandra
    Valentino, Paola
    Cavalla, Paola
    Maimone, Davide
    Sola, Patrizia
    Granella, Franco
    Pesci, Ilaria
    Rovaris, Marco
    Simone, Marta
    Trojano, Maria
    Amato, Maria Pia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [5] Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis
    Rocca, Maria Assunta
    Mesaros, Sarlota
    Pagani, Elisabetta
    Sormani, Maria Pia
    Comi, Giancarlo
    Filippi, Massimo
    RADIOLOGY, 2010, 257 (02) : 463 - 469
  • [6] Predicting long-term sustained disability progression in multiple sclerosis
    Sharmin, S.
    Malpas, C.
    Horakova, D.
    Havrdova, E. K.
    Izquierdo, G.
    Eichau, S.
    Trojano, M.
    Prat, A.
    Girard, M.
    Duquette, P.
    Onofrj, M.
    Lugaresi, A.
    Grand'Maison, F.
    Grammond, P.
    Sola, P.
    Ferraro, D.
    Terzi, M.
    Hupperts, R.
    Alroughani, R.
    Boz, C.
    Shaygannejad, V.
    Van Pesch, V.
    Cartechini, E.
    Kappos, L.
    Lechner-Scott, J.
    Bergamaschi, R.
    Turkoglu, R.
    Solaro, C.
    Ramo-Tello, C.
    Iuliano, G.
    Granella, F.
    Van Wijmeersch, B.
    Spitaleri, D.
    Bolanos, R. F.
    Slee, M.
    McCombe, P.
    Prevost, J.
    Ampapa, R.
    Ozakbas, S.
    Sanchez-Menoyo, J. L.
    Soysal, A.
    Vucic, S.
    Petersen, T.
    Verheul, F.
    Butler, E.
    Hodgkinson, S.
    Sidhom, Y.
    Gouider, R.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 119 - 121
  • [7] Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis
    Sharmin, Sifat
    Bovis, Francesca
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Trojano, Maria
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Grammond, Pierre
    Sola, Patrizia
    Ferraro, Diana
    Terzi, Murat
    Hupperts, R. M. M.
    Alroughani, Raed
    Boz, Cavit
    Shaygannejad, Vijay
    Van Pesch, Vincent
    Kappos, Ludwig
    Lechner-Scott, Jeannette
    Bergamaschi, Roberto
    Turkoglu, Recai
    Solaro, Claudio
    Ramo-Tello, Cristina
    Iuliano, Gerardo
    Granella, Franco
    Van Wijmeersch, Bart
    Spitaleri, Daniele Litterio A.
    Fernandez Bolanos, Ricardo
    Slee, Mark
    McCombe, Pamela
    Prevost, Julie
    Ampapa, Radek
    Ozakbas, Serkan
    Luis Sanchez-Menoyo, Jose
    Soysal, Aysun
    Vucic, Ostoja
    Petersen, Thor
    Verheul, Freek
    Butler, Ernest
    Hodgkinson, Suzanne
    Sidhom, Youssef
    Gouider, Riadh
    Cristiano, Edgardo
    Olascoaga Urtaza, Francisco Javier
    NEUROLOGY, 2020, 94 (15)
  • [8] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, Maria
    Butzkueven, Helmut
    Kappos, Ludwig
    Wiendl, Heinz
    Spelman, Tim
    Pellegrini, Fabio
    Pellegrini, Fabio
    Dong, Qunming
    Kondgen, Harold
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP2 - NP2
  • [9] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, M.
    Butzkueven, H.
    Kappos, L.
    Wiendl, H.
    Spelman, T.
    Pellegrini, F.
    Chen, Y.
    Dong, Q.
    Koendgen, H.
    Belachew, S.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 562 - 563
  • [10] Long term disability progression in early and late onset pediatric multiple sclerosis patients
    De Meo, E.
    Fonderico, M.
    Filippi, M.
    Patti, F.
    Morra, V. Brescia
    Salemi, G.
    Lus, G.
    Onofrji, M.
    Cocco, E.
    Maniscalco, G.
    Bertolotto, A.
    Confalonieri, P.
    Bergamaschi, R.
    Lugaresi, A.
    Valentino, P.
    Sola, P.
    Cavalla, P.
    Maimone, D.
    Granella, F.
    Pesci, I.
    Rovaris, M.
    Simone, M.
    Trojano, M.
    Amato, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 464 - 464